Advanced molecular cytogenetics in human and mouse

Kathleen Dorritie, Cristina Montagna, Michael J. Difilippantonio, Thomas Ried

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Fluorescence in situ hybridization, spectral karyotyping, multiplex fluorescence in situ hybridization, comparative genomic hybridization, and more recently array comparative genomic hybridization, represent advancements in the field of molecular cytogenetics. The application of these techniques for the analysis of specimens from humans, or mouse models of human diseases, enables one to reliably identify and characterize complex chromosomal rearrangements resulting in alterations of the genome. As each of these techniques has advantages and limitations, a comprehensive analysis of cytogenetic aberrations can be accomplished through the utilization of a combination approach. As such, analyses of specific tumor types have proven invaluable in the identification of new tumor-specific chromosomal aberrations and imbalances (aneuploidy), as well as regions containing tumor-specific gene targets. Application of these techniques has already improved the classification of tumors into distinct categories, with the hope that this will lead to more tailored treatment strategies. These techniques, in particular the application of tumor-specific flourerscense in situ hybridization probes to interphase nuclei, are also powerful tools for the early identification of premalignant lesions.

Original languageEnglish (US)
Pages (from-to)663-676
Number of pages14
JournalExpert Review of Molecular Diagnostics
Volume4
Issue number5
DOIs
StatePublished - Sep 2004
Externally publishedYes

Fingerprint

Cytogenetics
Comparative Genomic Hybridization
Neoplasms
Fluorescence In Situ Hybridization
Chromosome Aberrations
Spectral Karyotyping
Interphase
Aneuploidy
In Situ Hybridization
Genome
Genes

Keywords

  • Array CGH
  • Comparative cytogenetics
  • Comparative genomics
  • Cytogenetic
  • DOP-PCR
  • Fluorescent in situ hybridization
  • Fluorochromes
  • Hybridization
  • M-FISH
  • Microarrays
  • Mouse models
  • Multiplex FISH
  • Spectral karyotyping

ASJC Scopus subject areas

  • Genetics

Cite this

Advanced molecular cytogenetics in human and mouse. / Dorritie, Kathleen; Montagna, Cristina; Difilippantonio, Michael J.; Ried, Thomas.

In: Expert Review of Molecular Diagnostics, Vol. 4, No. 5, 09.2004, p. 663-676.

Research output: Contribution to journalArticle

Dorritie, Kathleen ; Montagna, Cristina ; Difilippantonio, Michael J. ; Ried, Thomas. / Advanced molecular cytogenetics in human and mouse. In: Expert Review of Molecular Diagnostics. 2004 ; Vol. 4, No. 5. pp. 663-676.
@article{09c21664c07a426288ac38cfcb4a8972,
title = "Advanced molecular cytogenetics in human and mouse",
abstract = "Fluorescence in situ hybridization, spectral karyotyping, multiplex fluorescence in situ hybridization, comparative genomic hybridization, and more recently array comparative genomic hybridization, represent advancements in the field of molecular cytogenetics. The application of these techniques for the analysis of specimens from humans, or mouse models of human diseases, enables one to reliably identify and characterize complex chromosomal rearrangements resulting in alterations of the genome. As each of these techniques has advantages and limitations, a comprehensive analysis of cytogenetic aberrations can be accomplished through the utilization of a combination approach. As such, analyses of specific tumor types have proven invaluable in the identification of new tumor-specific chromosomal aberrations and imbalances (aneuploidy), as well as regions containing tumor-specific gene targets. Application of these techniques has already improved the classification of tumors into distinct categories, with the hope that this will lead to more tailored treatment strategies. These techniques, in particular the application of tumor-specific flourerscense in situ hybridization probes to interphase nuclei, are also powerful tools for the early identification of premalignant lesions.",
keywords = "Array CGH, Comparative cytogenetics, Comparative genomics, Cytogenetic, DOP-PCR, Fluorescent in situ hybridization, Fluorochromes, Hybridization, M-FISH, Microarrays, Mouse models, Multiplex FISH, Spectral karyotyping",
author = "Kathleen Dorritie and Cristina Montagna and Difilippantonio, {Michael J.} and Thomas Ried",
year = "2004",
month = "9",
doi = "10.1586/14737159.4.5.663",
language = "English (US)",
volume = "4",
pages = "663--676",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - Advanced molecular cytogenetics in human and mouse

AU - Dorritie, Kathleen

AU - Montagna, Cristina

AU - Difilippantonio, Michael J.

AU - Ried, Thomas

PY - 2004/9

Y1 - 2004/9

N2 - Fluorescence in situ hybridization, spectral karyotyping, multiplex fluorescence in situ hybridization, comparative genomic hybridization, and more recently array comparative genomic hybridization, represent advancements in the field of molecular cytogenetics. The application of these techniques for the analysis of specimens from humans, or mouse models of human diseases, enables one to reliably identify and characterize complex chromosomal rearrangements resulting in alterations of the genome. As each of these techniques has advantages and limitations, a comprehensive analysis of cytogenetic aberrations can be accomplished through the utilization of a combination approach. As such, analyses of specific tumor types have proven invaluable in the identification of new tumor-specific chromosomal aberrations and imbalances (aneuploidy), as well as regions containing tumor-specific gene targets. Application of these techniques has already improved the classification of tumors into distinct categories, with the hope that this will lead to more tailored treatment strategies. These techniques, in particular the application of tumor-specific flourerscense in situ hybridization probes to interphase nuclei, are also powerful tools for the early identification of premalignant lesions.

AB - Fluorescence in situ hybridization, spectral karyotyping, multiplex fluorescence in situ hybridization, comparative genomic hybridization, and more recently array comparative genomic hybridization, represent advancements in the field of molecular cytogenetics. The application of these techniques for the analysis of specimens from humans, or mouse models of human diseases, enables one to reliably identify and characterize complex chromosomal rearrangements resulting in alterations of the genome. As each of these techniques has advantages and limitations, a comprehensive analysis of cytogenetic aberrations can be accomplished through the utilization of a combination approach. As such, analyses of specific tumor types have proven invaluable in the identification of new tumor-specific chromosomal aberrations and imbalances (aneuploidy), as well as regions containing tumor-specific gene targets. Application of these techniques has already improved the classification of tumors into distinct categories, with the hope that this will lead to more tailored treatment strategies. These techniques, in particular the application of tumor-specific flourerscense in situ hybridization probes to interphase nuclei, are also powerful tools for the early identification of premalignant lesions.

KW - Array CGH

KW - Comparative cytogenetics

KW - Comparative genomics

KW - Cytogenetic

KW - DOP-PCR

KW - Fluorescent in situ hybridization

KW - Fluorochromes

KW - Hybridization

KW - M-FISH

KW - Microarrays

KW - Mouse models

KW - Multiplex FISH

KW - Spectral karyotyping

UR - http://www.scopus.com/inward/record.url?scp=4544247507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4544247507&partnerID=8YFLogxK

U2 - 10.1586/14737159.4.5.663

DO - 10.1586/14737159.4.5.663

M3 - Article

C2 - 15347260

AN - SCOPUS:4544247507

VL - 4

SP - 663

EP - 676

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 5

ER -